Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLight Science Technologies Regulatory News (LST)

Share Price Information for Light Science Technologies (LST)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.00 (0.00%)
Bid:
1.70
Ask:
1.90
Spread: 0.20 (11.765%)
Market Cap: £17.71m
LST Live PriceLast checked at - London Stock Exchange

Intraday Light Science Technologies Share Chart

Total Voting Rights

30 Apr 2026 07:00

RNS Number : 4539C
Light Science Tech. Holdings PLC
30 April 2026
 

Light Science Technologies Holdings plc

("LSTH", "Light Science", the "Company" or the "Group")

 

Total Voting Rights

 

Light Science Technologies Holdings plc (AIM: LST), the innovative technology and manufacturing business providing real-world solutions targeting issues including global food security and fire safety, announces that the issued share capital of the Company at the date of this announcement comprises 993,005,500 ordinary shares of 1 pence each in the Company ("Ordinary Shares"), with one voting right per Ordinary Share. The Company does not hold any Ordinary Shares in treasury, therefore the total number of Ordinary Shares and voting rights in the Company is 993,005,500.

 

The above figure of 993,005,500 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For additional information please contact:

 

Light Science Technologies Holdings plc

Simon Deacon, Chief Executive Officer

Jim Snooks, Chief Financial Officer

Andrew Hempsall, Chief Operating Officer

 

www.lightsciencetechnologiesholdings.com

via Walbrook PR

 

Shore Capital (Nominated Adviser and Broker)

Stephane Auton / George Payne

 

+44 (0)20 7408 4050

Walbrook PR Ltd (Media & Investor Relations)

Nick Rome / Marcus Ulker

Tel: +44 (0)20 7933 8780 or lst@walbrookpr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRPPUQUCUPQGAB
Date   Source Headline
10th Jun 20264:54 pmRNSHolding(s) in Company
10th Jun 20267:00 amRNSManufacturing Partnership & Capacity Expansion
9th Jun 202610:14 amRNSHolding(s) in Company
5th Jun 20267:00 amRNSGrant of Share Options
22nd May 202612:37 pmRNSResult of AGM
11th May 20261:53 pmRNSHolding(s) in Company
7th May 20267:00 amRNSCEM Contract Win
6th May 20267:00 amRNS-RInvestor Evening
5th May 20267:00 amRNSFirst order as Injectaclad supplier
30th Apr 20267:00 amRNSTotal Voting Rights
24th Apr 20267:00 amRNSFinal Results, Analyst and Investor Presentations
17th Apr 20261:40 pmRNSHolding(s) in Company
17th Apr 20267:00 amRNSNotice of Results, Analyst Briefing, Investor Pres
16th Apr 20267:00 amRNSHolding(s) in Company
15th Apr 20264:32 pmRNSHolding(s) in Company
15th Apr 20262:44 pmRNSHolding(s) in Company
15th Apr 20262:42 pmRNSHolding(s) in Company
15th Apr 20267:00 amRNSCompletion of Acquisitions
14th Apr 20264:22 pmRNSHolding(s) in Company
14th Apr 20261:26 pmRNSHolding(s) in Company
14th Apr 202612:04 pmRNSHolding(s) in Company
9th Apr 202611:52 amRNSResult of General Meeting & Total Voting Rights
9th Apr 20268:05 amRNS-RBSR Strategic Plan: Positive Implications for PFP
31st Mar 20267:00 amRNSTotal Voting Rights
30th Mar 20267:00 amRNSAgTech Contract Win
20th Mar 20261:29 pmRNSHolding(s) in Company
18th Mar 20264:38 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSResult of Retail Offer
17th Mar 20267:00 amRNSResult of Retail Offer
11th Mar 20269:58 amRNSResult of Placing
11th Mar 20269:58 amRNSResult of Placing
11th Mar 20267:10 amRNSLaunch of Retail Offer
11th Mar 20267:10 amRNSLaunch of Retail Offer
11th Mar 20267:00 amRNSAcquisitions and Fundraise to raise up to £6.6m
11th Mar 20267:00 amRNSAcquisitions and Fundraise to raise up to £6.6m
3rd Nov 20251:00 pmRNS-RAgTech - UK Parliamentary Group Calls for Action
27th Oct 20257:00 amRNSAgTech Contract Win
15th Oct 20257:00 amRNS-RAgTech Update
29th Sep 20257:00 amRNS-RPFP Division Secures BSA Accreditation
25th Sep 20257:00 amRNSHolding(s) in Company
16th Sep 20257:00 amRNSHolding(s) in Company
26th Aug 20257:00 amRNSContract Wins
20th Aug 20255:46 pmRNSHolding(s) in Company
20th Aug 202512:13 pmRNSHolding(s) in Company
18th Aug 20252:32 pmRNSHolding(s) in Company
15th Aug 202511:16 amRNSHolding(s) in Company
15th Aug 20257:00 amRNSCEM Contract Wins
14th Aug 20254:30 pmRNSHolding(s) in Company
13th Aug 20257:00 amRNSHalf-year Report
5th Aug 20257:00 amRNSNotice of Results, Analyst Briefing, Investor Pres

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.